TPM4 and ovarian carcinoma: Following treatment with platelet releasate, SK-OV-3 cells also showed expression changes in genes involved in, anti-autophagy in endometrial and ovarian cancer [KIAA1324/EIG121], as well as transcriptional regulation [ACTL6A], cell cycle[MUS81], cytoskeletal [TPM4] and homeostatic [TPM4] processes [47], [48].